CUREXO’s spinal surgery robot, ‘CUVIS-spine’ acquired FDA (US) licensing.

  • ‘CUVIS-spine’ is available in all countries by acquiring the license from the FDA (US), Korea and Europe.
  • ‘CUVIS-spine’ reduces surgery duration with Minimally Invasive Surgery (MIS).

SEOUL, South Korea, May 21, 2021 /PRNewswire/ — On the 20th, the Medical robot specialist company CUREXO Corp. (060280) announced their independently developed spinal surgery robot ‘CUVIS-spine’ has acquired FDA (US) licensing.

This FDA (US) license, followed by Korea (2019) and Europe CE (2020) certificate is the 3rd license that they have acquired and now their product can be supplied to all countries.